Tokyo Tape
Sign in
← Hyuga Primary Care

Half-year report · HY

7133.TEDINET S100X2MF
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥5.5bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥10.0bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥4.7bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥226m2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥449m2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥206m2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥1.0bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥435m2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥205m2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥435m2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥136m2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥719m2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥291m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥136m2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥291m2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥8.2bnat 2025-09-30Cons.Assets
Total assets¥7.1bnat 2025-03-31Cons.Assets
Total assets¥6.9bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥5.9bnat 2025-09-30Cons.Liabilities
Total liabilities¥4.7bnat 2025-03-31Cons.Liabilities
Net assets / equity¥2.4bnat 2025-09-30Cons.Net assets
Net assets / equity¥2.4bnat 2025-03-31Cons.Net assets
Net assets / equity¥1.9bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥754mat 2025-09-30Cons.Cash and deposits
Cash and deposits¥566mat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥754mat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥566mat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥889mat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥688mat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow−¥134m2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥771m2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥188m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥527m2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥474m2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥188m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥849m2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥419m2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥201m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥19.12025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥101.122024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥41.032024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥18.552025-04-01 → 2025-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥97.922024-04-01 → 2025-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥39.622024-04-01 → 2024-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio28.7%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.6%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio28.0%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-04-01 → 2025-09-30¥373,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-04-01 → 2025-09-30¥373,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-04-01 → 2025-09-30−¥18m
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2025-09-30−¥298m
Home Visit Pharmacist Servicereportable segmentrevenue2025-04-01 → 2025-09-30¥3.9bn
Home Visit Pharmacist Servicereportable segmentrevenue external2025-04-01 → 2025-09-30¥3.9bn
Home Visit Pharmacist Servicereportable segmentsegment profit2025-04-01 → 2025-09-30¥228m
Kirari Primereportable segmentrevenue2025-04-01 → 2025-09-30¥591m
Kirari Primereportable segmentrevenue external2025-04-01 → 2025-09-30¥591m
Kirari Primereportable segmentsegment profit2025-04-01 → 2025-09-30¥342m
Primary Care Homereportable segmentrevenue2025-04-01 → 2025-09-30¥1.0bn
Primary Care Homereportable segmentrevenue external2025-04-01 → 2025-09-30¥1.0bn
Primary Care Homereportable segmentsegment profit2025-04-01 → 2025-09-30−¥28m
—segment totalrevenue2025-04-01 → 2025-09-30¥5.5bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥5.5bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥542m
Total Of Reportable Segments And Otherssegment totalrevenue2025-04-01 → 2025-09-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-04-01 → 2025-09-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2025-04-01 → 2025-09-30¥524m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥420,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥420,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30−¥4m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥296m
Home Visit Pharmacist Servicereportable segmentrevenue2024-04-01 → 2024-09-30¥3.4bn
Home Visit Pharmacist Servicereportable segmentrevenue external2024-04-01 → 2024-09-30¥3.4bn
Home Visit Pharmacist Servicereportable segmentsegment profit2024-04-01 → 2024-09-30¥277m
Kirari Primereportable segmentrevenue2024-04-01 → 2024-09-30¥544m
Kirari Primereportable segmentrevenue external2024-04-01 → 2024-09-30¥544m
Kirari Primereportable segmentsegment profit2024-04-01 → 2024-09-30¥338m
Primary Care Homereportable segmentrevenue2024-04-01 → 2024-09-30¥759m
Primary Care Homereportable segmentrevenue external2024-04-01 → 2024-09-30¥759m
Primary Care Homereportable segmentsegment profit2024-04-01 → 2024-09-30¥134m
—segment totalrevenue2024-04-01 → 2024-09-30¥4.7bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥4.7bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥749m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥4.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥4.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥745m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 455
ItemContextValueUnit
Net assetsPrior1YearInstant2371782000JPY
Net assetsInterimInstant2365644000JPY
Liabilities and net assetsPrior1YearInstant7051212000JPY
Liabilities and net assetsInterimInstant8233783000JPY
Net salesPrior1InterimDuration4719387000JPY
Net salesInterimDuration5532096000JPY
Cost of salesPrior1InterimDuration3624629000JPY
Cost of salesInterimDuration4567730000JPY
Gross profitPrior1InterimDuration1094758000JPY
Gross profitInterimDuration964365000JPY
Selling general and administrative expensesPrior1InterimDuration646220000JPY
Selling general and administrative expensesInterimDuration738458000JPY
Operating incomePrior1InterimDuration448537000JPY
Operating incomeInterimDuration225907000JPY
Interest income noiPrior1InterimDuration1751000JPY
Interest income noiInterimDuration2471000JPY
Subsidy income noiPrior1InterimDuration2689000JPY
Subsidy income noiInterimDuration1584000JPY
Gain on sales of noncurrent assets noiPrior1InterimDuration－JPY
Gain on sales of noncurrent assets noiInterimDuration538000JPY
Other noiPrior1InterimDuration107000JPY
Other noiInterimDuration1405000JPY
Non operating incomePrior1InterimDuration4547000JPY
Non operating incomeInterimDuration5999000JPY
Interest expenses noePrior1InterimDuration17904000JPY
Interest expenses noeInterimDuration25639000JPY
Other noePrior1InterimDuration43000JPY
Other noeInterimDuration185000JPY
Non operating expensesPrior1InterimDuration17948000JPY
Non operating expensesInterimDuration25824000JPY
Ordinary incomePrior1InterimDuration435136000JPY
Ordinary incomeInterimDuration206082000JPY
Impairment loss elPrior1InterimDuration－JPY
Impairment loss elInterimDuration842000JPY
Extraordinary lossPrior1InterimDuration－JPY
Extraordinary lossInterimDuration842000JPY
Income before income taxesPrior1InterimDuration435136000JPY
Income before income taxesInterimDuration205239000JPY
Income taxesPrior1InterimDuration143807000JPY
Income taxesInterimDuration69027000JPY
Profit lossPrior1InterimDuration291328000JPY
Profit lossInterimDuration136212000JPY
Profit loss attributable to non controlling interestsPrior1InterimDuration－JPY
Profit loss attributable to non controlling interestsInterimDuration－JPY
Profit loss attributable to owners of parentPrior1InterimDuration291328000JPY
Profit loss attributable to owners of parentInterimDuration136212000JPY
Profit lossPrior1InterimDuration291328000JPY
Profit lossInterimDuration136212000JPY
Other comprehensive incomePrior1InterimDuration－JPY
Other comprehensive incomeInterimDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass